InmodeIL0011595993INMDINMD
Financials
Market Cap
$1.44B5Y beta
2.20EPS (TTM)
$2.305Free Float
76.42MP/E ratio (TTM)
7.38Revenue (TTM)
$492.05MEBITDA (TTM)
$196.28MFree Cashflow (TTM)
$176.12MPricing
Analyst Ratings
The price target is $27.60 and the stock is covered by 6 analysts.
Buy
3
Hold
3
Sell
0
Information
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.